![Kenneth Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kelley
Algemeen Directeur bij
IDBiologics, Inc.
Profiel
Kenneth J. Kelley is een zakenman die IntraBiotics Pharmaceuticals, Inc. en Emergent Travel Health, Inc. heeft opgericht en aan het hoofd heeft gestaan van 7 verschillende bedrijven. Momenteel is hij voorzitter van Seromyx Systems, Inc. en voorzitter van Selva Therapeutics, Inc. De heer Kelley zit ook in de raad van bestuur van Halozyme Therapeutics, Inc. (voormalig Voorzitter), Meissa Vaccines, Inc., Actym Therapeutics, Inc. en IDBiologics, Inc. en Managing Director bij K2 BioVentures LLC. In zijn vorige loopbaan was Kenneth J. Kelley Bestuurder bij Solus Biosystems, Inc., Voorzitter van Fluxion Biosciences, Inc., General Partner bij Latterell Venture Partners, Associate bij Institutional Venture Partners, Consultant bij McKinsey & Co., Inc., Voorzitter & Chief Executive Officer bij IntraBiotics Pharmaceuticals, Inc., Bestuurder bij Emergent Travel Health, Inc. en Wetenschapper bij Integrated Genetics, Inc. Kenneth J. Kelley behaalde een bachelorgraad aan de Harvard University en een MBA aan de Stanford University.
Actieve functies van Kenneth Kelley
| Bedrijven | Functie | Begin |
|---|---|---|
K2 BioVentures LLC | Corporate Officer/Principal | 07-07-2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Directeur/Bestuurslid | 27-03-2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Directeur/Bestuurslid | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Algemeen Directeur | 01-01-2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Voorzitter | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Voorzitter | - |
Eerdere bekende functies van Kenneth Kelley
| Bedrijven | Functie | Einde |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Voorzitter | 01-01-2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Corporate Officer/Principal | 01-06-2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Directeur/Bestuurslid | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Kenneth Kelley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
19
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 19 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Health Technology |
Kies MarketScreener 
